Epstein-barr Virus-associated Lymphoproliferative Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-09-09
Clinical Trial Update: Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy [Phase 4]
A Phase 4 clinical trial update investigating a PD-1 monoclonal antibody as first-line therapy for EBV-related hemophagocytic lymphohistiocy…